Ajanta Pharma (NSE:AJANTPHARM) E10: ₹64.00 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:AJANTPHARM Ajanta Pharma Ltd NSE:AJANTPHARM
95 GF Score
Price ₹3,481.70
GF Value ₹3,348.50
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Ajanta Pharma E10?

Ajanta Pharma NSE:AJANTPHARM -0.66% 95 E10 is ₹64.00 as of Jun. 2026. GuruFocus rates NSE:AJANTPHARM with a GF Score™ of 95/100 and a GF Value™ of ₹3,348.50 (Fairly Valued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Ajanta Pharma's adjusted earnings per share data for the three months ended in Jun. 2026 was ₹26.720. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹64.00 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Ajanta Pharma's average E10 Growth Rate was 11.30% per year. During the past 3 years, the average E10 Growth Rate was 9.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Ajanta Pharma was 9.40% per year. The lowest was 7.70% per year. And the median was 8.55% per year.

As of today (2026-09-03), Ajanta Pharma's current stock price is ₹3481.70. Ajanta Pharma's E10 for the quarter that ended in Jun. 2026 was ₹64.00. Ajanta Pharma's Shiller PE Ratio of today is 54.40.

During the past 13 years, the highest Shiller PE Ratio of Ajanta Pharma was 63.51. The lowest was 24.69. And the median was 42.18.


Ajanta Pharma  (NSE:AJANTPHARM) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Ajanta Pharma's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=3481.70/64.00
=54.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Ajanta Pharma was 63.51. The lowest was 24.69. And the median was 42.18.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Ajanta Pharma E10 Related Terms


Ajanta Pharma E10 Historical Data

* Premium members only.

The historical data trend for Ajanta Pharma's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ajanta Pharma E10 Chart

Ajanta Pharma Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 44.63 47.10 50.54 55.81 61.64

Ajanta Pharma Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 57.50 59.22 60.39 61.64 64.00

NSE:AJANTPHARM vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Ajanta Pharma's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ajanta Pharma Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ajanta Pharma's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Ajanta Pharma's Shiller PE Ratio falls into.


NSE:AJANTPHARM
95GF Score
Ajanta Pharma Ltd NSE:AJANTPHARM
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ajanta Pharma E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Ajanta Pharma's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=26.72/167.3573*167.3573
=26.720

Current CPI (Jun. 2026) = 167.3573.

Ajanta Pharma Quarterly Data

per share eps CPI Adj_EPS
201609 9.900 105.961 15.636
201612 10.793 105.196 17.171
201703 8.633 105.196 13.734
201706 7.180 107.109 11.219
201709 9.987 109.021 15.331
201712 11.173 109.404 17.092
201803 7.160 109.786 10.915
201806 8.013 111.317 12.047
201809 9.500 115.142 13.808
201812 5.067 115.142 7.365
201903 6.733 118.202 9.533
201906 8.760 120.880 12.128
201909 8.887 123.175 12.075
201912 8.213 126.235 10.888
202003 9.867 124.705 13.242
202006 11.287 127.000 14.874
202009 13.000 130.118 16.721
202012 13.607 130.889 17.398
202103 11.953 131.771 15.181
202106 13.390 134.084 16.713
202109 15.100 135.847 18.603
202112 14.770 138.161 17.891
202203 11.700 138.822 14.105
202206 13.630 142.347 16.025
202209 12.220 144.661 14.137
202212 10.500 145.763 12.056
202303 9.540 146.865 10.871
202306 16.530 150.280 18.408
202309 15.500 151.492 17.123
202312 16.670 152.924 18.243
202403 16.090 153.035 17.596
202406 19.530 155.789 20.980
202409 17.260 157.882 18.296
202412 18.590 158.323 19.651
202503 18.000 157.552 19.120
202506 20.430 159.755 21.402
202509 20.820 162.289 21.470
202512 21.910 163.281 22.457
202603 21.340 164.272 21.741
202606 26.720 167.357 26.720

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹64.00 mean?
Ajanta Pharma (NSE:AJANTPHARM) has a E10 of ₹64.00 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Ajanta Pharma and its competitors.
Is Ajanta Pharma's E10 too high?
Ajanta Pharma's current E10 is ₹64.00. Overall, Ajanta Pharma has a GF Score™ of 95/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ajanta Pharma's E10 compare to ZTS?
Ajanta Pharma's E10 of ₹64.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Ajanta Pharma and its competitors. Ajanta Pharma's current E10 is ₹64.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ajanta Pharma stock overvalued right now?
Based on GuruFocus' analysis, Ajanta Pharma (NSE:AJANTPHARM) is currently considered Fairly Valued. The stock's GF Value™ is ₹3,348.50, compared to a current price of ₹3,481.70 — trading 4% above its estimated fair value. The current E10 is ₹64.00. Ajanta Pharma's overall GF Score™ is 95/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Ajanta Pharma (NSE:AJANTPHARM), the current E10 is ₹64.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ajanta Pharma (NSE:AJANTPHARM) Overvalued in 2026?

Based on GuruFocus' analysis, Ajanta Pharma stock appears to be overvalued. The current stock price of ₹3,481.70 is trading 4% above its estimated GF Value™ of ₹3,348.50. GuruFocus considers Ajanta Pharma to be Fairly Valued.

Key valuation signals for NSE:AJANTPHARM:

  • E10: ₹64.00
  • GF Value™: ₹3,348.50 vs. price of ₹3,481.70 (4% above fair value)
  • GF Score™: 95/100 with 6 warning signs

No single metric tells the full story. See the NSE:AJANTPHARM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ajanta Pharma Business Description

Other Exchanges 532331:India
Address M Vasanji Road, Ajanta Tower, 54-A, Chakala, Andheri East, Mumbai, MH, IND, 400 093
Ajanta Pharma Ltd is mainly involved in development, manufacturing and marketing of speciality pharmaceutical finished dosages. The operations of the Group are limited to only one segment viz. pharmaceuticals and related products. The company has presence in India, Emerging Market, Africa Institution, and USA. The company generates majority of revenue from Emerging market.
95GF Score

Get the complete analysis for NSE:AJANTPHARM

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹3,481.70
Price
₹3,348.50
GF Value